BIO-REFERENCE LABS INC-NEW-
BRLI
BRLI was delisted on the 19th of August, 2015.
175 hedge funds and large institutions have $609M invested in BIO-REFERENCE LABS INC-NEW- in 2013 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 54 increasing their positions, 66 reducing their positions, and 23 closing their positions.
294% more call options, than puts
Call options by funds: $14M | Put options by funds: $3.56M
0% more funds holding
Funds holding: 175 → 175 (0)
0% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 23
17% less capital invested
Capital invested by funds: $735M → $609M (-$126M)
18% less repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 66
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BTW
Boston Trust Walden
Boston,
Massachusetts
|
+$36.5M |
| 2 |
EIP
Epoch Investment Partners
New York
|
+$12.9M |
| 3 |
CGI
CI Global Investments
Oakland,
California
|
+$8.47M |
| 4 |
RP
Riverbridge Partners
Minneapolis,
Minnesota
|
+$8.16M |
| 5 |
VM
Valinor Management
New York
|
+$7.21M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$51.8M |
| 2 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$20.5M |
| 3 |
SCA
Summit Creek Advisors
Minneapolis,
Minnesota
|
-$12.3M |
| 4 |
CM
CS McKee
Pittsburgh,
Pennsylvania
|
-$12M |
| 5 |
PIM
Provident Investment Management
Novi,
Michigan
|
-$11M |
BRLI Hedge Fund Activity: Q4 2013 in Review
175 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in BIO-REFERENCE LABS INC-NEW- (BRLI) for Q4 2013, worth a combined $609M — down 17% from $735M a quarter earlier.
Fund positioning in BRLI was balanced in Q4 2013: 23 funds opened new positions, 23 closed out, 54 added to existing stakes and 66 trimmed.
The largest buyer was Boston Trust Walden, opening a new position worth an estimated $36.5M. The largest seller was Jennison Associates, cutting an estimated $51.8M.
- 175 institutional investors held BIO-REFERENCE LABS INC-NEW- (BRLI) as of Q4 2013, unchanged from Q3 2013.
- Funds reported $609M of BIO-REFERENCE LABS INC-NEW- stock for Q4 2013, down 17% quarter-over-quarter.
- 23 funds opened new BIO-REFERENCE LABS INC-NEW- positions in Q4 2013 and 23 closed out, a net change of 0 holders.
- The largest BIO-REFERENCE LABS INC-NEW- buyer in Q4 2013 was Boston Trust Walden, an estimated $36.5M added.
- The largest BIO-REFERENCE LABS INC-NEW- seller in Q4 2013 was Jennison Associates, an estimated $51.8M sold.
Based on aggregated 13F filings for Q4 2013.